Steven Tong

Professor

Peter Doherty Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Steven Tong is a faculty member at the Peter Doherty Institute in Australia. His research focuses on infectious diseases, particularly bloodstream infections, mycobacterial infections, and adherence to quality-of-care indicators. He has contributed significantly to understanding treatment outcomes in various bacterial infections and the complexities of clinical trials within this field.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Noah Wald-Dickler

Hospital Epidemiologist & Chief of Infectious Disease

UCLA Medical Center

UNITED STATES

View details

Paula Binks

Charles Darwin University

AUSTRALIA

View details

Christopher Selman

Murdoch Childrens Research Institute

AUSTRALIA

View details

Benjamin P. Howden

AUSTRALIA

View details

Katherine Gibney

University of Melbourne

AUSTRALIA

View details

Joshua S. Davis

AUSTRALIA

View details

Sean Ong

Peter Doherty Institute

AUSTRALIA

View details

Jonathan Carapetis

University of Western Australia

AUSTRALIA

View details

Todd Lee

Associate Professor of Medicine

McGill University

CANADA

View details

Asha Bowen

University of Western Australia

AUSTRALIA

View details

Claire Gorrie

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steven Tong

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clinical course of patients with bloodstream infections enrolled in the BALANCE clinical trial

Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post-hoc Analysis of Individual Participant Data from Two Randomized Trials.

Trials Within Trials-Optimizing the Delivery of RCTs.

Making Sense of Hierarchical Composite End Points in Randomized Clinical Trials—A Primer for Infectious Diseases Clinicians and Researchers

Disease progression & treatment need in sub-genotype C4 hepatitis B infection

Practicing With Intent: How to Teach an Old Dogma New Tricks

<i>Mycobacterium abscessus</i> Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.

Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial.

Inclusion of a low- and middle-income country site in the Staphylococcus aureus Network Adaptive Platform trial: experiences from Johannesburg.

Bacterial and fungal infections in persons who inject drugs.

Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study

Heterogeneity in Risk of Newly Classified “Typical” Streptococci as Causes of Infective Endocarditis

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus.

Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.

The impact of rapid diagnostic testing on hospital administrative coding accuracy for influenza.

Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysis.

In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery.

Unlocking the DOOR-how to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials.

Influenza-associated hospitalisation and mortality rates among global Indigenous populations; a systematic review and meta-analysis

Collaborators (11)

Noah Wald-Dickler

Paula Binks

Christopher Selman

Benjamin P. Howden

Katherine Gibney

Joshua S. Davis

Sean Ong

Jonathan Carapetis

Todd Lee

Asha Bowen

Claire Gorrie

Make your next move.

Steven Tong

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clinical course of patients with bloodstream infections enrolled in the BALANCE clinical trial

Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post-hoc Analysis of Individual Participant Data from Two Randomized Trials.

Trials Within Trials-Optimizing the Delivery of RCTs.

Making Sense of Hierarchical Composite End Points in Randomized Clinical Trials—A Primer for Infectious Diseases Clinicians and Researchers

Disease progression & treatment need in sub-genotype C4 hepatitis B infection

Practicing With Intent: How to Teach an Old Dogma New Tricks

&lt;i&gt;Mycobacterium abscessus&lt;/i&gt; Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.

Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial.

Inclusion of a low- and middle-income country site in the Staphylococcus aureus Network Adaptive Platform trial: experiences from Johannesburg.

Bacterial and fungal infections in persons who inject drugs.

Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study

Heterogeneity in Risk of Newly Classified “Typical” Streptococci as Causes of Infective Endocarditis

A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus.

Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.

The impact of rapid diagnostic testing on hospital administrative coding accuracy for influenza.

Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysis.

In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery.

Unlocking the DOOR-how to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials.

Influenza-associated hospitalisation and mortality rates among global Indigenous populations; a systematic review and meta-analysis

Collaborators (11)

Noah Wald-Dickler

Paula Binks

Christopher Selman

Benjamin P. Howden

Katherine Gibney

Joshua S. Davis

Sean Ong

Jonathan Carapetis

Todd Lee

Asha Bowen

Claire Gorrie

Make your next move.

<i>Mycobacterium abscessus</i> Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.